The outgoing and incoming signals from IFIT+_BCs and B-like cells to CD8_TCs1 and CD8_TCs2 are persistently strengthened, aligning with the established role of B cells in mediating CD8+ T cell immune responses in tumor control. The gene discussed is CD8A; the disease is neoplasm.